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A “one material fits all” mindset ignores profound differences in target tissues that affect their 
responses and reactivity. Yet little attention has been paid to the role of diseased tissue on material 
performance, biocompatibility, and healing capacity. We assessed material-tissue interactions with 
a prototypical adhesive material based on dendrimer:dextran and colon as a model tissue platform. 
Adhesive materials have high sensitivity to changes in their environment and can be exploited to 
probe and quantify the influence of even subtle modifications in tissue architecture and biology. 
We studied inflammatory colitis and colon cancer and found, not only a difference in adhesion 
related to surface chemical interactions, but also the existence of a complex interplay that 
determined the overall dendrimer:dextran biomaterial compatibility. Compatibility was contextual, 
not simply a constitutive property of the material, and was related to the extent and nature of 
immune cells in the diseased environment present prior to material implantation. We then showed 
how to use information about local alterations of the tissue microenvironment to assess disease 
severity. This in turn guided us to an optimal dendrimer:dextran formulation choice using a 
predictive model based on clinically relevant conditions.
INTRODUCTION
Biomaterials are increasingly used to support or reprogram their complex biological 
microenvironment by either providing structural stability and mechanical restoration or by 
serving as scaffolds for local drug release or for embedding of cells. Further, materials have 
been functionalized with biological sequences of natural components to attract reparative 
endogenous cells and modulate their phenotypes (1–5). Despite the use of such materials in 
injured, inflamed, or diseased environments, little has been reported about the impact of 
disease on the material itself and whether the material performs its intended action in 
selected environments. Materials with adequate efficacy in a healthy environment might 
demonstrate suboptimal performance and altered host-material responses in diseased 
settings. Although the inflammatory response to material exposure follows an orderly 
sequence of events, preexisting processes such as inflammation might set this order awry. 
The sequence of early neutrophil invasion followed by macrophage infiltration and 
eventually the formation of foreign-body giant cells is modified in a disease state (6). 
Disease alters the basal immune state, as immune cells are present at the site of injury well 
before any material is implanted. Such is the case of inflammatory diseases, in which the 
preexisting tissue reactivity might alter tissue response to a material. We envisioned that 
rational development of materials with optimal healing capacity can be enabled only in the 
context of the intended clinical use of the material and with a deep understanding of the 
local environment.
We used the gastrointestinal tract as a model system to study the impact of disease on the 
tissue microenvironment and two disease models—inflammation and neoplasia—which we 
surmised would span a range of cellular responses and a spectrum of reactions to a material. 
Adhesive materials are ideal candidates with which to study the effects of gut disease on 
performance given their intimate interaction with tissue in this defined locale and their 
clinical relevance in mediating complications associated with leakage after surgical gut 
repair (7). We recently showed that adhesive dendrimer:dextran-based materials facilitate 
the probing of local changes in tissue surface chemistry by virtue of their distinct 
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interactions with different target tissues (7, 8). Here we exploit this feature to examine, in 
our model systems, the effects of disease-driven alterations in local tissue-state on the tissue 
microenvironment and the clinical implications of such alterations. We show that 
carcinogenesis and inflammation of the colon are two distinct processes that present 
substantially different surfaces—driven by their biochemistry and cell biology—to the 
external environment. Interaction of the dendrimer:dextran material with tissue surfaces and 
tissue responses to this adhesive material were altered in a disease type– and pathological 
state–dependent manner. The interrelationship between material science and tissue biology 
should be considered as we seek to facilitate predictive and controlled material performance 
in specific clinical scenarios. Concepts learned from these studies might illuminate general 
guidelines by which to assess material-tissue interactions and their disease-driven 
alterations.
RESULTS
Characterization of tissue surface chemistry and material performance in colon cancer 
and colitis
We used two different animal models for studying the impact of local pathology on 
dendrimer:dextran performance across species and recapitulated the chemical, structural, 
and biological cues characteristic of a particular disease in a specific location. We used a 
commercially available rat orthotopic model for colon cancer and developed a colitis model 
in rabbits that provided sufficient tissue biopsies to conduct mechanical testing, characterize 
tissue chemistry, and build a predictive model that informs material choice for each disease 
severity.
Dextran aldehyde reacts internally with dendrimer amines to form a hydrogel and with tissue 
amines to provide adhesion. To understand the extent to which tissue surface chemistry was 
altered by cancer or colitis in our model systems, we quantified the interaction of aldehyde-
coated microspheres with healthy and diseased tissues as a measure of tissue-amine binding 
sites. We hypothesized that microsphere adhesion in colon cancer would exhibit alterations 
in concert with changes in tissue surface amine density. Indeed, a significant increase in 
amine density was detected with fluorescent aldehyde-coated microspheres in cancerous 
colon tissue (Fig. 1A, i–ii), which displayed a greater number of chemical groups that were 
available for material interaction. A concomitant increase in material adhesion (Fig. 1A, iii–
iv) was detected by fluorescence intensity at the interfacial region (defined as the area of the 
biomaterial that interacts with the tissue and has a morphology distinct from the rest of the 
material (fig. S1, a and b). Smaller and fewer pores of reduced area (U=interfacial pores 
area) were present within a narrower interfacial region [W= interfacial width; W= 104.7 ± 
20.8 μm and U = 5.85×102 ± 7.77×101 μm2 for cancerous rat tissue and W= 130.3 ± 27.9 
μm and U = 5.44×103 ± 1.75×103 μm2 for healthy rat tissue; fig. S1, c and d; P<0.05 by 
two-tailed t-test for independent samples], which indicated that interfacial adhesion and 
integration of the material were enhanced. Macroscopic-force measurement of adhesion 
failure (as determined with a mechanical tester, see Materials and Methods) rose 43% (from 
0.566 ± 0.08 N to 0.808 ± 0.04 N) for colon cancer tissue compared to healthy colon tissue 
(Fig. 1C, P<0.05, by two-tailed t-test for independent samples; data tabulated in table S1). 
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This increase in maximum load correlated with observed microscopic changes, as indicated 
by higher interfacial fluorescence and amine density.
In contrast, amine density was lower in inflammatory colitis compared to the healthy state 
(Fig. 1B, i–ii). Material-tissue adhesion was reduced in colitis tissue (Fig. 1B, iii–iv and fig. 
S1e) as indicated by a wider interfacial region as well as a higher pore area (W=216.3 ± 37.5 
μm and U=1.39×104 ± 2.84×103 μm2) compared with that of healthy colon tissue (W=108.3 
± 38.6 μm and U=3.40×103 ± 1.13×103 μm2; fig. S1, f and g; P<0.05 by two-tailed t-test for 
independent samples). The reduction in tissue binding sites, indicated by microsphere 
conjugation, translated into inferior material adhesion strength as corroborated by a 58% 
reduction in the mechanical load required to break the bond between the colitic tissue and 
our material relative to the healthy state (from 0.812 ± 0.16 N to 0.34 ± 0.13 N, respectively) 
(Fig. 1D, P<0.05 by two-tailed t-test for independent samples; data tabulated in table S1).
We then examined whether dendrimer:dextran formulation protocols can compensate for the 
reduced availability of tissue binding sites in colitis. Material composition spanned a wide 
range of adhesion strengths (Fig. 1E; data tabulated in table S2). As dextran aldehyde solid 
content was increased from 7.5 to 25 wt%, maximal load at failure increased 235% (from 
0.25±0.03 N to 0.83 ±0.22 N, P<0.05 by two-tailed t-test for independent samples) (7, 9). 
The excess aldehydes provided by raises in the dextran aldehyde solid content increased the 
probability for material interaction with tissue amines. Indeed, by increasing dextran 
aldehyde solid content from 10 wt% in healthy tissue to 25 wt% in the case of colitis, we 
were able to compensate for the reduction in tissue amine density in the disease state and 
achieve the same level of adhesion strength as in the healthy state (Fig. 1F; data tabulated in 
table S3).
Determination of diseased-tissue surface chemistry by collagen quantification
To understand the underlying mechanism that mediated tissue surface chemistry 
modifications in the context of cancer and colitis, we characterized the primary tissue 
proteins in healthy and diseased tissues. Collagen I accounts for ~70% of the total collagen 
in gastrointestinal tissues (10). Using cryosectioned tissue, we measured a significant 
increase in collagen content in vitro in the presence of neoplasia (fig. S2). The same trend 
was observed when we quantified collagen and bound microspheres on healthy and 
cancerous tissue surfaces (en face) with an in vivo imaging system. These findings suggest 
that a higher number of amine groups reside on the surface of cancerous versus healthy 
colon tissue (Fig. 2A; data tabulated in table S4).
In contrast, inflammation is known to result in collagen degradation and tissue surface 
remodeling as a consequence of the release, by neutrophils, of factors that activate matrix 
metalloproteinases such as MMP-8 (also known as collagenase-2 or neutrophil collagenase). 
We hypothesized that disease-driven changes in collagen levels on the surface of the gut 
lumen, where the disease originates, would disseminate to the external surface of the gut—
the serosa (peritoneum-facing)—where the material is applied. If this is the case, then 
alteration of tissue serosal surface chemistry would affect material performance.
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To examine this hypothesis, we induced colitis in rabbits by instilling 2,4-
dinitrobenzenesulfonic acid (DNBS) intra-colonially and tested whether collagen content 
and hence, amine concentration varied on the serosal side of the gut (Fig. 2, B and C). We 
observed a reduction in collagen content throughout the three layers of the intestinal wall of 
colitic tissue (Fig. 3A, i and iii), and this effect disseminated to the serosal layer, as evident 
by the reduction in en face collagen content (Fig. 3A, iv–vi) and in microsphere conjugation 
(Fig. 2B; data tabulated in table S5). There was a strong linear correlation (R2=0.99, Fig. 
2C) between serosal en face collagen I content and serosal tissue amines (as measured by 
microspheres conjugation), and this relation was maintained across species (rats and rabbits; 
Fig. 2C).
Deciphering the impact of disease severity on tissue microenvironment
Colitis presents clinically as a range of severities. We investigated whether differential 
luminal degrees of inflammation would disseminate to the serosal side in a disease-severity 
dependent manner. We instilled various concentrations of DNBS into rabbit colons to 
achieve a range of disease severities and then validated our model through quantification of 
tumor necrosis factor alpha (TNF-α and neutrophil recruitment in the gut (fig. S3a, i–vi). 
TNF-α is known to be upregulated in inflammatory bowel disease in humans (11) because it 
is released in the context of inflammation by immune-surveillance macrophages present in 
the mucosal layer of the colon (12). TNF-α upregulation then leads to neutrophil recruitment 
to the gut mucosa, tissue infiltration and subsequent release of MMP-8, which degrades 
collagen in the basement membrane (13). Indeed, TNF-α release increased over a 7.4-fold 
range (from 30.9 ± 8.57 to 229.2 ±27.67 in relative fluorescence) with the severity of 
induced colitis, while neutrophils recruitment was increased in a correlative manner (5.5-
fold; from 10.7 ± 13.51 to 60.4 ± 5.93 in relative fluorescence) (fig. S3b). As a result, we 
observed a correlative 1.7-fold decrease in basement-membrane collagen (from 336.6 ± 8.05 
to 218.7 ± 15.65 in relative fluorescence) (Fig. 3A, i–iii, fig. S3b).
We also observed a linear correlation between en face collagen content in the serosa (Fig. 
3A, iv–vi) and the extent of inflammation, as measured by the recruitment of neutrophils to 
the gut, thus corroborating the transmural nature of this disease in our rabbit model (fig. S4a, 
R2=0.97). This decrease in serosal collagen level was further supported by a decrease in 
surface amine density, which correlated linearly with serosal collagen content (fig. 4b, 
R2=0.94). These findings suggest that one can use the rapid measure of surface amine 
density to guide one’s choice of adhesive properties in a dendrimer:dextran material in a 
way that is clinically relevant and yields information on disease severity. Such properties 
might facilitate a more personalized selection of materials for colitis treatment than is 
currently possible.
Building a predictive model to guide material choice
Colitic tissues with different degrees of inflammation were tested for amine density and 
adhesion strength using three different material formulations of varying aldehyde content 
(10%, 15%, and 20%). For a particular formulation, adhesion strength decreases with 
disease severity in a linear fashion. As we increase dextran aldehyde solid content, the slope 
of this curve increases, indicating higher adhesion strength (Fig. 3B). Interestingly, there is a 
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linear correlation between the slope of these curves and dextran solid content (R2=0.99, Fig. 
3C). Hence, we can predict adhesion strength of a new formulation for any disease state 
using these relationships. Indeed, there was an excellent agreement between the calculated 
and predicted adhesion strengths of 25% dextran aldehyde formulation applied to tissue 
surfaces that are healthy, or with mild and severe colitis (R2=0.99, with errors smaller than 
6%, Fig. 3D). We envision performing rapid assessment of amine density in the operating 
room on patients’ biopsies to guide surgeons on the optimal material formulation to be used, 
in a patient-specific manner, such that adequate adhesion will be achieved.
Evaluation of material biocompatibility and healing capacity in vivo
We examined inflammation in the implant area as well as biological response to a 
dendrimer:dextran material (serosal heterophils) and healing capacity (serosal fibrosis) 
compared to use of sutures in vivo for healthy compared to colitic or cancerous tissues. 
Healthy rat colonic tissue appeared normal in structure (Fig. 4A, i and fig. S5a, i–iii), and 
the colorectal cancer rat model verified the existence of a mass of abnormal tissue with 
differentiated cells forming the tumor (Fig. 4A, ii and fig. S5a, iv–vi). Similarly, healthy 
rabbit colonic tissue appeared normal with intact mucosal and serosal layers (Fig. 4A, iii and 
fig. S5b, i–iii), while colitic tissue presented as diffusely necrotic mucosa with an intense 
heterophilic inflammatory response (Fig. 4a, iv and fig. S5b, iv–vi).
The levels of inflammation were not statistically distinguishable when dendrimer:dextran 
material was applied to the serosal layer of lacerated healthy or cancerous tissue in the 
presence or absence of the adhesive (Fig. 4, B and C). The difference in heterophil (that is, 
granular leukocytes) recruitment to the serosal layer was not statistically significant when 
sutures alone were used compared to sutures plus adhesive, both in healthy and cancerous 
states (Fig. 4, B and C). Serosal fibrosis was similar with and without adhesive application 
in healthy tissue (Fig. 4B; data tabulated in table S6). When sutures alone were applied, 
tissue fibrosis was reduced in the cancerous state compared to the healthy state. Application 
of adhesive material to cancerous tissue improved healing to levels comparable to those of 
healthy tissue, as measured by serosal fibrosis (Fig. 4C; data tabulated in table S7). Colitic 
tissue presents with higher total inflammation whether sutures alone or sutures plus material 
were applied, owing to the nature of the disease (Fig. 4E; data tabulated in table S9). The 
immune response to dendrimer:dextran was contextual; the number of serosal heterophils in 
lacerated healthy tissue was not altered upon material application to the serosal layer; in 
contrast, the difference in serosal heterophil numbers upon material application was 
statistically significant in the colitic state compared to sutures alone (Fig. 4, D and E; data 
tabulated in table S8). Similar to what was observed in the cancerous model, healing 
capacity (as measured by serosal fibrosis) after material application to the serosal layer in 
colitic tissue was improved compared to that of suture application alone, while healthy 
tissue presented good repair capacity irrespective of whether the adhesive material was used 
or not (Fig. 4, D and E).
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DISCUSSION
Variations in tissue surface chemistry between different tissue surfaces dictate their 
interaction with our adhesive material in healthy states (7, 8). We showed herein that tissue 
surface chemistry was modified to an even greater extent by local pathology relative to 
variations between different tissues in the healthy state. Pathological states exerted profound 
effects on tissue:biomaterial interactions and material performance for dendrimer dextran 
adhesive hydrogel. Tissue surface chemistry (amine content) and the biological 
microenvironment were significantly altered in the face of inflammation and neoplasia.
To understand the impact of tissue surface modification by a disease on dendrimer:dextran 
material performance, we quantified surface collagen levels as a predictive measure for 
adhesion strength. Amino acids from structural proteins are the main anchoring points for 
amine-reactive adhesives and thus can be used to define adhesion strength. We used serosal 
collagen I as a measure for assessing amine density because it comprises ~70% of all 
collagen and is the most prevalent protein in the gastrointestinal tract. Colorectal cancer is 
driven by unbridled cell proliferation and an abundant extracellular matrix response with 
marked elevation in internal collagen levels, which are reflected on the surface and 
subsequently accompanied by increased amine binding sites. This indeed resulted in a 43% 
increase in adhesion strength in tumoral compared to healthy tissue.
The question that arises is whether there would be a similar alteration in tissue surface 
chemistry in a disease that originates remotely from the tissue surface, as in the case of 
inflammatory colitis. The inflammatory reaction of colitis is most intense at the luminal side, 
presenting irregular or obliterated crypts, inflammatory cell infiltrates in the lamina propria, 
and abscess formation at the bottom of the crypts (14). Serosal surface–interacting materials 
such as adhesives are thus removed from the major source of tissue alteration, yet we 
observed that deep tissue injury manifested as reduced amine density on the serosa 
compared to healthy tissue. Inflammation elicits neutrophil recruitment across the colon, 
starting from the mucosa and covering the serosa. As the infiltrating neutrophils release 
metalloproteinases, they break down collagen to allow for tissue remodeling and healing. 
Indeed, adhesion strength in colitic tissue with ~80% less collagen I (Fig. 2B) was 58% 
lower than that achieved for healthy tissue (Fig. 1D). The significant alteration of tissue 
surface chemistry in pathological states reiterates the importance of understanding the 
disease impact on the tissue microenvironment in the selection of dendrimer:dextran 
material formulation and also might be helpful in the design of other surface-interacting 
biomaterials.
Dendrimer:dextran performance was not only affected by different pathological processes, 
such as carcinogenesis and inflammation, but it is also affected by the state of a particular 
disease. For example, different severities of colitis imparted graded variation in tissue amine 
density and, hence, required different adhesive material formulations to achieve the desired 
adhesion level. We built a dataset to create a predictive model that informed on the 
appropriate material formulation choice given a specific colitic severity (data points plotted 
in Fig. 3B). The data set described adhesion strengths for three different dendrimer:dextran 
material formulations as a function of a range of colitis severities (measured by amine 
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density). A linear regression model was fit to each material formulation (Fig. 3B), and the 
slopes of the curves were plotted as a function of aldehyde-solid content, yielding a linear 
relationship (Fig. 3C). The slope of a new material formulation with a defined dextran 
aldehyde-solid content, 25%, was extrapolated from this fit (Fig. 3C, red triangle). The 
model was validated by comparing the measured adhesion strengths using a mechanical 
tester with the calculated ones after ex vivo application of the 25% solid content material 
formulation to tissues with three different degrees of colitis severities (Fig. 3D). As 
expected, there was an inverse linear correlation between disease severity and adhesion 
strength as a result of amine density loss (Fig. 3B). Providing more aldehyde groups to react 
with a tissue with low amine density can compensate for the reduction in adhesion strength 
resulting from collagen loss. The obtained linear relationships allowed us to construct a 
mathematical fit for the data, which in turn enabled us to predict the adhesion strength of a 
completely new dendrimer:dextran formulation when applied to either healthy, mild, or 
severe colitic states (Fig. 3, C and D). If this approach can be implemented in a clinical 
setting where a patient’s colorectal biopsy can be rapidly analyzed for amine density, it 
would allow the surgeon to choose the optimal adhesive formulation on the basis of an 
individual patient’s needs. This practice would help prevent material failure and improve 
patient outcome.
Dendrimer:dextran biocompatibility was also disease-dependent as measured by the 
recruitment of serosal heterophils to the interface with the adhesive material (Fig. 4, BE). 
Differences in disease-specific basal immunity—as evident from total inflammatory scores 
at tissue sites prior to injury and treatment—may explain these variable responses. Although 
basal immunity varies dramatically in colitic versus healthy tissue, the basal inflammatory 
score in the cancerous state was similar to that of a healthy state (Fig. 4, B and C). These 
trends correlated with the levels of heterophils recruitment upon dendrimer:dextran 
application compared to suture application alone (Fig. 4, C and E), being higher in colitic 
versus cancerous tissue. Assessing both the basal immune state as well as disease-specific 
immune responses was crucial to deciphering material compatibility. Healing capacity 
followed the same trend in both models—although our material did not affect healing in 
healthy tissues, application to diseased tissues improved healing capacity. This may result in 
part from improved mechanical stability and alleviation of local stresses imparted by the 
sutures when our material was applied. For both diseases, total inflammation was identical 
whether dendrimer:dextran was applied or not, further supporting the role of mechanical 
stability in the differential healing responses.
Our data reveal the profound effect of pathological states on tissue:biomaterial interactions 
and material performance and increase our understanding of how biological forces 
manifested by disease type and severity affect dendrimer:dextran adhesive performance. 
With a predictive model to account for those changes, we could rationally tune our 
material’s adhesive strengths to be comparable to those of healthy tissue. Furthermore, 
changes in the tissue microenvironments altered dendrimer:dextran performance in our 
colon cancer and colitis models relative to healthy tissues, suggesting that an understanding 
of the diseased tissue microenvironment is key for successful translation.
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An understanding of tissue:material interactions provides new vistas for materials research 
and characterization of therapeutic potential. Other materials and pathologies might display 
determinant factors that differ from those of our model adhesive hydrogel. For instance, 
materials that undergo oxidative degradation will degrade faster in the tumor environment as 
a result of an elevation in the concentration of reactive oxygen species. Similarly, natural 
materials that undergo enzymatic degradation will degrade differentially depending on the 
enzyme concentrations in an inflammatory environment relative to the basal healthy state.
Materials and Methods
Study design
The objective of this study was to investigate the effects of two pathological states [gut 
inflammation (colitis), in rabbits and colon neoplasia, in rats) on dendrimer:dextran adhesion 
(Fig. 1, C–F), biocompatibility (Fig. 4), and healing capacity (Fig. 4). With the information 
obtained from the adhesion studies and exploiting the tunable properties of our material, we 
were able to generate a data set and establish a curve fitting with the purpose of predicting 
material adhesion strength under a range of inflammatory states.
A linear regression model was fit to each material formulation and the slopes of the curves 
were plotted as a function of aldehyde solid content, yielding a linear relationship. The slope 
of a new material formulation with a defined dextran aldehyde solid content, 25%, was 
extrapolated from this fit. The model was validated by comparing the measured adhesion 
strengths using a mechanical tester with the calculated ones following ex vivo application of 
the 25% solid content material formulation to tissues with three different degrees of colitis 
severities. This model also allowed us to choose, on the basis of inflammatory disease 
severity, the material formulation to achieve the desired level of adhesion.
All animals (rats and rabbits) were randomly assigned to control and experimental groups, 
with the exception of experiments in which different strains were used as control and 
experimental groups (Sprague-Dawley rats as controls, which were compared with Pirc rats, 
an experimental model of human familial colon cancer). Sample size was determined by 
power analysis to achieve a minimum effect size of 0.5 with a P value of less than 0.05. 
Sample sizes vary between experiments and are specified in each figure caption as well as 
the corresponding Materials and Methods section.
Synthesis and formation of dendrimer/dextran hydrogels
Dendrimer/dextran networks were fabricated as previously described (7). Briefly, generation 
five polyamidoamine (PAMAM) dendrimers with 25% amine surface groups (Dendritech 
Inc.) were dissolved in water and mixed with a solution of oxidized dextran (50% oxidation 
of glucose rings, 2 aldehyde groups per oxidized glucose ring). The two homogeneous 
polymer solutions were loaded into a dual-chamber syringe equipped with a 8-step mixing 
tip. Dendrimer:dextran network formation occurred within seconds after mixing.
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Fluorescent dendrimer amine
To characterize the dendrimer/dextran morphology at the tissue material interface, 
constituent dendrimer amine was labeled with fluorescein as previously described (7). 
Briefly, PAMAM dendrimer (Dendritech Inc.) was mixed with fluorescein-NHS (Life 
Technologies) in 50mM bicarbonate buffer for 2 hours. Then, the product was dialyzed 
using a 10 kDa cutoff filter and lyophilized overnight.
Colitis model in rabbits
Disease model of colitis was developed in rabbits (2.5 to 3 kg, male New Zealand White 
Rabbits, Charles River) by rectal instillation of 2,4-dinitrobenzenesulfonic acid (DNBS, 
Sigma-Aldrich). Colitis induction protocol was reviewed and approved by the Committee in 
Animal Care at MIT. DNBS in 25% ethanol (1 ml) was instilled through a urethral catheter 
introduced 15 cm into the rectum. Concentrations of DNBS were 150 and 75 mg/ml for 
severe and mild colitis induction, respectively. Animals were sacrificed 24 hours post-
instillation and colon tissues excised.
Colon cancer model in rats
Male PIRC rats (350–400 g, retired breeder F344/NTac-Apcam1137, Taconic) were used as 
colorectal cancer model and male Sprague-Dawley rats (250 to 300 g, Charles River 
Laboratories) as control.
Tissue surface amine density
To determine the aldehyde affinity of colorectal healthy and diseased tissues, the 
conjugation of aldehyde-coated fluorescent microspheres (f-MS) (Molecular Probes) to 
tissue surfaces was quantified as previously described (7). For fluorescent microscopy 
purposes, tissue specimens were snap frozen overnight, cryosectioned (16-μm sections), and 
stained with propidium iodide (Vector Laboratories). For en face amine density 
quantification, sections were imaged in the Xenogen IVIS device with the appropriate filter 
sets (N=10 for colitis studies and N=3 for cancer studies). The fluorescence intensity was 
determined by calculating the efficiency overlying each construct, where the fluorescence 
intensity was corrected to eliminate tissue autofluorescence.
Adhesive interface morphology
To investigate the morphology of the interface between the adhesive and tissue surfaces, 
biopsied tissues were covered with 100 μL of fluorescently labeled dendrimer/dextran 
(dendrimer solution containing 0.5% tagged dendrimer) that was allowed to cure for 4 min. 
Tissue samples were snap frozen overnight, cryosectioned (12-μm sections), and stained 
with propidium iodide (Vector Laboratories). The morphology of the tissue material 
interface was quantified as the fluorescence intensity of fluorescein at the interface using 
image analysis (NIS-Elements, Nikon). The interfacial pore size and length were also 
measured using NIS-Elements (N=5 for each tissue type and formulation).
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Adhesion mechanics
The adhesion mechanics following dendrimer/dextran application to soft tissues was 
measured using an Instron mechanical tester, as previously described (7). Briefly, 
dendrimer:dextran was applied between two uniformly sized rat colonic tissue biopsies (6 
μm diameter) and allowed to polymerize for 5 min. Then, uniaxial tensile testing (Instron 
ElectroPuls E3000) was employed at a constant rate (0.05 mm/s) and the load response was 
continuously recorded to the point of macroscopic failure (N=5 for each tissue type and 
formulation).
Collagen-I immunofluorescence staining
Primary anti-collagen I antibody (Abcam) and Alexa Fluor 488 goat anti-mouse secondary 
antibody (Life Technologies) were used. For fluorescent microscopy purposes, tissue 
specimens were snap frozen overnight and cryosectioned (12-μm sections). 
Immunofluorescence staining against collagen I was performed using standard methods and 
tissues were stained with propidium iodide (Vector Laboratories). Collagen contents in the 
submucosa and basement membrane of the colon were quantified using image analysis (N=5 
for each tissue type; NIS-Elements, Nikon). For en face collagen, tissues were processed and 
quantified as described for en face amine density (N=10 for colitis studies and N=3 for 
cancer studies).
TNF-α immunofluorescence staining
Primary anti-TNF-α antibody (Santa Cruz Biotechnology) and goat anti-rabbit IgG 
fluorescein conjugate secondary antibody (EMD Millipore) were used. Tissue specimens 
processed as described for collagen immunofluorescence staining. TNF-α content in the 
colonic mucosa was quantified using image analysis (N=5 for each tissue type; NIS-
Elements, Nikon).
Neutrophil immunofluorescence staining
Primary anti-MAC-387 (FITC) antibody (Abcam) was used, which recognizes the 
Calprotectin molecule, an intra-cytoplasmic antigen expressed by granulocytes, monocytes 
and tissue macrophages. Tissue specimens were processed as described for collagen 
immunofluorescence staining. Neutrophil recruitment to the submucosa and basement 
membrane of the colon was quantified using image analysis (N=5 for each tissue type; NIS-
Elements, Nikon).
Enterotomy procedure
Enterotomy procedures were performed in both models of colitis and colon cancer, as well 
as in healthy controls, by creating an incision in the colon and applying sutures to the 
anastomoses site with or without the application of dendrimer:dextran adhesive material. 
Enterotomy studies were reviewed and approved by the Committee in Animal Care at MIT. 
Harvested tissue was excised a week post-surgery and cryosectioned to create 10-μm-thick 
sections. Hematoxylin and eosin staining was performed using standard methods. 
Histological slides were evaluated for their extent of inflammation, serosal heterophils and 
serosal fibrosis using the following scores: 0, no observable change compared to the control; 
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1, a nearly imperceptible feature (minimal); 2, an easily identifiable or notable (mild/
moderate) feature; 3, a prominent to overwhelming (marked/severe) feature (N=5 for each 
experimental group).
Statistical analyses
Data are presented as mean ± standard deviation. Graphs were created using GraphPad 
Prism software. All statistical comparisons were performed with a two-tailed t-test for 
independent samples using VassarStats software (Vassar College, Poughkeepsie, NY, USA). 
A P value of <0.05 was considered to denote statistical significance. Data marked with the 
same symbol (for example, single asterisk or double asterisk) represent values with 
statistical significance between them.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Assessment of tissue:material interactions and mechanical properties as a function of 
disease type
(A) Amine density on colon serosal layer was assessed by aldehyde-coated fluorescent 
microspheres (green) in rat healthy (i) and cancerous (ii) tissues (red, stained with propidium 
iodide); and dendrimer:dextran adhesive (green, tagged with fluorescein) morphology when 
applied to rat healthy (iii) and neoplastic (iv) tissues (red, stained with propidium iodide). 
(B) Aldehyde-coated fluorescent microspheres (green) and dendrimer:dextran morphology 
(green, tagged with fluorescein) applied to rabbit healthy (I and iii) and inflamed (ii and iv) 
tissues (red, stained with propidium iodide). Maximum load at failure measured for (C) 
healthy and cancerous tissues and (D) healthy and inflamed tissues. (E) Maximum load at 
failure measured for different material formulations (dextran aldehyde solid contents from 
7.5 to 25% with fixed dendrimer amine solid content of 20%) on healthy rabbit colon (P< 
0.05). Dextran aldehyde solid content can be tuned to match the surface amine density of the 
target tissue. (D) By increasing dextran aldehyde solid content from 10% to 25%, 
statistically equal levels of adhesion can be achieved in healthy and inflamed tissues, 
respectively. For all mechanical testing data, N=5 for each experimental group. In each 
graph, data marked with the same symbol represents statistical significance with P<0.05.
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Fig. 2. Affect of colitis on collagen I content transluminally
Amine density and surface collagen content were quantified en face using aldehyde coated 
fluorescent microspheres and anti-collagen I antibody, respectively, in (A) healthy and 
cancerous rat tissues (N =3 for each experimental group) and (B) healthy and colitic rabbit 
tissues (N=10 for each experimental group). (C) High correlation is achieved between 
collagen and amine density en face (R2=0.99, P< 0.05). In each graph, data marked with the 
same symbol represents statistical significance with P<0.05.
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Fig. 3. Effect of disease severity on material performance
(A) Immunofluorescence staining against collagen, both for basement membrane collagen 
(cryosection staining, i to iii) and serosal collagen (en face staining, iv–vi), was performed in 
rabbits using healthy, mild and severe colitic tissues. (B) Maximum load at failure as a 
function of amine density and hence, inflammation severity, for a range of material 
formulations (D10, 15, 20 represent dextran aldehyde with 10, 15, or 20% solid content, and 
G20 is PAMAM dendrimer 20% solid content; N=20 of varying degrees of inflammation for 
each adhesive formulation). (C) The slopes of the curve fits for maximum load at failure as a 
function of inflammation severity linearly correlate with dextran aldehyde solid content (10, 
15, and 20%). This correlation was used to predict the slope for a new dextran solid content 
of 25% (D25, red triangle in the graph). (D) Experimental (measured) and predicted 
(calculated using model) adhesion strengths of a new formulation (D25 and G20) applied to 
three tissue samples spanning a range of inflammatory severities (N=1 for each 
inflammation severity).
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Fig. 4. Adhesive-mediated healing capacity
(A) Hematoxylin and eosin (H&E) staining of (i) healthy and (ii) cancerous rat tissues and 
(iii) healthy and (iv) inflammed rabbit tissues following incision, suturing and adhesive 
application. Histological scoring of inflammation, serosal heterophils, and serosal fibrosis in 
the case of (B) healthy and (C) cancerous rat tissues and (D) healthy and (E) colitic rabbit 
tissues (N=5 for each experimental group). In each graph, data marked with the same 
symbol represents statistical significance, with P<0.05.
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